Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
Sponsor: Hopital Foch
A NA clinical study on Mayer Rokitansky Kuster Hauser Syndrome, this trial is actively recruiting participants. The trial is conducted by Hopital Foch and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Recruiting NA
-
Apr 2025 — Jun 2025 [monthly]
Recruiting NA
-
Sep 2024 — Apr 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2022 — Jul 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Sep 2019 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2018 — Sep 2019 [monthly]
Recruiting NA
-
Oct 2018 — Nov 2018 [monthly]
Recruiting NA
First recorded
Dec 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hopital Foch
For direct contact, visit the study record on ClinicalTrials.gov .